Anti-Yo autoimmunity; dangerous for the brain but not the tumor?

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 1-2

  Greenlee, John E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; IMMUNOGLOBULIN;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; AUTOIMMUNITY; CANCER INHIBITION; CEREBROSPINAL FLUID; DIAGNOSTIC IMAGING; EDITORIAL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; OCCULT CANCER; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PURKINJE CELL; T LYMPHOCYTE ACTIVATION; TUMOR DIAGNOSIS;

AUTOANTIBODIES; CARCINOMA; EARLY DIAGNOSIS; HUMANS; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; POSITRON-EMISSION TOMOGRAPHY;

EID: 33750504631     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.08.001     Document Type: Editorial

References (20)

1. Peterson K., Rosenblum M.K., Kotanides H., and Posner J.B. Paraneoplastic cerebellar degeneration: I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42 (1992) 1931-1937
2. Felician O., Renard J.L., Vega F., Creange A., Chen Q.M., Bequet D., et al. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man. Neurology 45 (1995) 1226-1227
3. Meglic B., Graus F., and Grad A. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma. J Neurol Sci 185 (2001) 135-138
4. Sutton I.J., Fursdon Davis C.J., Esiri M.M., Hughes S., Amyes E.R., and Vincent A. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol 49 (2001) 253-257
5. Rojas I., Graus F., Keime-Guibert F., Rene R., Delattre J.Y., Ramon J.M., et al. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology 55 (2000) 713-715
6. Rojas-Marcos I., Rousseau A., Keime-Guibert F., Rene R., Cartalat-Carel S., Delattre J.Y., et al. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine (Baltimore) 82 (2003) 216-223
7. Linke R., Schroeder M., Helmberger T., and Voltz R. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology 63 (2004) 282-286
8. Younes-Mhenni S., Janier M.F., Cinotti L., Antoine J.C., Tronc F., Cottin V., et al. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127 (2004) 2331-2338
9. Greenlee J.E., and Brashear H.R. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14 (1983) 609-613
10. Jaeckle K.A., Graus F., Houghton A., Cordon-Cardo C., Nielsen S.L., and Posner J.B. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic antigen. Ann Neurol 18 (1985) 592-600
11. Dropcho E.J., Chen Y.T., Posner J.B., and Old L.J. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 84 (1987) 4552-4556
12. Furneaux H.M., Dropcho E.J., Barbut D., Chen Y.T., Rosenblum M.K., Old L.J., et al. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 86 (1989) 2873-2877
13. Fathallah-Shaykh H., Wolf S., Wong E., Posner J.B., and Furneaux H.M. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A 88 (1991) 3451-3454
14. Sakai K., Mitchell D.J., Tsukamoto T., and Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 28 (1990) 692-698
15. Sakai K., Greenlee J.E., Jaeckle K.A., and Hirose G. The 52 kd expression product of PCD17, a cDNA cloned from human cerebellum, is uniformly recognized by sera and CSFs from patients with paraneoplastic cerebellar degeneration and Type I (anti-Yo) antibody response. Ann Neurol 32 (1992) 285-286
16. Tanaka K., Tanaka M., Igarashi S., Onodera O., Miyatake T., and Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg 97 (1995) 101-105
17. Tanaka M., Tanaka K., Onodera O., and Tsuji S. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein but do not cause Purkinje cell loss. Clin Neurol Neurosurg 97 (1995) 95-100
18. Graus F., Illa I., Agusta M., Ribalta T., Cruz-Sanchez F., and Juarez C. Effect of intraventricular injection of anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci 106 (1991) 82-87
19. Greenlee J.E., Burns J.B., Rose J.W., and Jaeckle K.A. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol (Berl) 89 (1995) 341-345
20. Sakai K., Gofuku M., Kitagawa Y., Ogasawara T., and Hirose G. Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein. J Neuroimmunol 60 (1995) 135-141